Digital biomarkers have been gaining momentum for the past few years and have seen justifiable hype over the past year as they have begun to be leveraged into consumer electronics. Digital biomarkers will underpin the future of healthcare, as they are emerging as a key technology tool in health and wellness, opening up new ways to use established sensors for early identification and management of disease.

In our report, “Opportunities In Digital Biomarkers”, we were able to identify sensors used in six categories: aging, mental and behavioral health, neurodegenerative and musculoskeletal disease, systemic illnesses, and other. These sensors are currently being investigated to create digital biomarkers that could be used to either detect or manage disease. This report will identify the most common data streams, their sources, and the conditions that are most commonly addressed by them – with an emphasis on which conditions are the most likely to see success in the near term.

Download the executive summary to learn more.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.